1. Guest, the 'News in Brief' for the week beginning 22nd February 2021 is here.
    Dismiss Notice
  2. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Kynurenine Trial in ME/CFS - Bergquist

Discussion in 'BioMedical ME/CFS News' started by Sly Saint, Aug 6, 2020.

Tags:
  1. Sly Saint

    Sly Saint Senior Member (Voting Rights)

    Messages:
    5,704
    Likes Received:
    47,033
    Location:
    UK
    STUDY AIM
    The purpose of the study is to evaluate whether kynurenine is directly connected to ME/CFS patient symptom severity.
    LEAD INVESTIGATORS
    • Jonas Bergquist, MD, PhD, Prof, Director ScD
    • Kumari Ubhayasekhera, PhD
    • Sandy Abujrais. PhD Student
    further details here
    https://www.omf.ngo/2020/08/05/kynurenine-trial-in-me-cfs/
     
    Sly Saint, Aug 6, 2020
    #1
    Andy, Joh, Rosie and 20 others like this.
  2. mango

    mango Senior Member (Voting Rights)

    Messages:
    1,153
    Likes Received:
    9,580
    mango, Aug 9, 2020
    #2
    Kitty and Caesar like this.
  3. JES

    JES Senior Member (Voting Rights)

    Messages:
    177
    Likes Received:
    1,056
    Nice. I was under the impression that Stanford would conduct the kynurenine trial and that Berquist et al. would be responsible for the pyridostigmine one, but anyway, I feel more excited about this one. At least this is something new I haven't seen previously attempted unlike with Mestinon.
     
    JES, Aug 9, 2020
    #3
    Perrier, obeat, Kitty and 1 other person like this.
  4. FMMM1

    FMMM1 Senior Member (Voting Rights)

    Messages:
    754
    Likes Received:
    2,861
    FMMM1, Nov 16, 2020
    #4
    Michelle, Perrier and Jaybee00 like this.
  5. Jaybee00

    Jaybee00 Senior Member (Voting Rights)

    Messages:
    634
    Likes Received:
    2,834
    Also posted the above in the sleep meds thread
     
    Jaybee00, Nov 16, 2020
    #5
    FMMM1 likes this.

Share This Page